Wiskott-Aldrich Syndrome Latest Advances

Redo ascending aorta and total arch replacement in patient with Wiskott-Aldrich syndrome: A case report.

Journal: Perfusion

Published: June 10, 2026

Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Journal: Nature medicine

Published: March 21, 2026

Wiskott-Aldrich syndrome and X-linked thrombocytopenia: a review of the clinical and immunological spectrum with a case presentation highlighting glomerulonephritis.

Journal: Frontiers in pediatrics

Published: March 16, 2026

Neurological manifestations in Wiskott-Aldrich syndrome: a systematic review.

Journal: Frontiers in immunology

Published: March 12, 2026

Partial splenic embolization bridging Wiskott-Aldrich syndrome: Managing frequent bleeding before curative therapy.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: March 10, 2026

An asymptomatic WASF1 truncation reveals pathogenic mechanism and therapeutic strategy for neurodevelopmental disorders.

Journal: Frontiers in behavioral neuroscience

Published: March 03, 2026

Massive Post-Endoscopic Duodenal Hematoma Causing Obstructive Pancreatitis in an Infant With Wiskott-Aldrich Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation.

Journal: Pediatric blood & cancer

Published: February 24, 2026

FDA approves gene therapy for Wiskott-Aldrich syndrome.

Journal: The Journal of allergy and clinical immunology

Published: February 04, 2026

In the IMD2 gene of Saccharomyces cerevisiae, the expression memory suppresses the induction of expression during guanosine triphosphate depletion.

Journal: PNAS nexus

Published: January 29, 2026

Etuvetidigene Autotemcel: First Approval.

Journal: Molecular diagnosis & therapy

Published: January 20, 2026

IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC).

Journal: The journal of allergy and clinical immunology. In practice

Published: January 17, 2026

Unmasking Wiskott-Aldrich Syndrome in Adulthood in a Case of Long-Standing Bleeding, Infections, and Steroid-Induced Morbidity.

Journal: Cureus

Published: December 30, 2025

Wiskott-Aldrich Syndrome Latest Advances

Find the Latest Research About Wiskott-Aldrich Syndrome

Redo ascending aorta and total arch replacement in patient with Wiskott-Aldrich syndrome: A case report.

Redo ascending aorta and total arch replacement in patient with Wiskott-Aldrich syndrome: A case report.

Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Author Correction: Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.

Wiskott-Aldrich syndrome and X-linked thrombocytopenia: a review of the clinical and immunological spectrum with a case presentation highlighting glomerulonephritis.

Wiskott-Aldrich syndrome and X-linked thrombocytopenia: a review of the clinical and immunological spectrum with a case presentation highlighting glomerulonephritis.

Neurological manifestations in Wiskott-Aldrich syndrome: a systematic review.

Neurological manifestations in Wiskott-Aldrich syndrome: a systematic review.

Partial splenic embolization bridging Wiskott-Aldrich syndrome: Managing frequent bleeding before curative therapy.

Partial splenic embolization bridging Wiskott-Aldrich syndrome: Managing frequent bleeding before curative therapy.

An asymptomatic WASF1 truncation reveals pathogenic mechanism and therapeutic strategy for neurodevelopmental disorders.

An asymptomatic WASF1 truncation reveals pathogenic mechanism and therapeutic strategy for neurodevelopmental disorders.

Massive Post-Endoscopic Duodenal Hematoma Causing Obstructive Pancreatitis in an Infant With Wiskott-Aldrich Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation.

Massive Post-Endoscopic Duodenal Hematoma Causing Obstructive Pancreatitis in an Infant With Wiskott-Aldrich Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation.

FDA approves gene therapy for Wiskott-Aldrich syndrome.

FDA approves gene therapy for Wiskott-Aldrich syndrome.

In the IMD2 gene of Saccharomyces cerevisiae, the expression memory suppresses the induction of expression during guanosine triphosphate depletion.

In the IMD2 gene of Saccharomyces cerevisiae, the expression memory suppresses the induction of expression during guanosine triphosphate depletion.

Etuvetidigene Autotemcel: First Approval.

Etuvetidigene Autotemcel: First Approval.

IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC).

IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC).

Unmasking Wiskott-Aldrich Syndrome in Adulthood in a Case of Long-Standing Bleeding, Infections, and Steroid-Induced Morbidity.

Unmasking Wiskott-Aldrich Syndrome in Adulthood in a Case of Long-Standing Bleeding, Infections, and Steroid-Induced Morbidity.